Next-Generation Sequencing (NGS) Kits Market Size, Share, Growth, and Industry Analysis, By Type (Blood Test, Saliva Test and Urine Test), By Application (Academic Research, Clinical Research and Hospitals and Clinics), and Regional Forecast to 2028

•   
•   
  

  Request a Free sample to learn more about this report

    

NEXT-GENERATION SEQUENCING (NGS) KITS MARKET OVERVIEW

The Next-Generation Sequencing (NGS) Kits Market, worth approximately USD 2.5 billion in 2024, is forecasted to increase to USD 2.77 billion in 2025 and surpass USD 6.2 billion by 2033, expanding at a CAGR of about 10.7% throughout the period 2025-2033.

The next-generation sequencing (NGS) kit market is shifting towards fast growth with the growing needs for sophisticated genetic analysis in therapeutic and educational settings. Owing to the growing incidence of cancer and genetic disorders, NGS has emerged as a potential diagnostic and personalized medicine instrument. Growing research on genetics has brought more reliance on NGS instruments in tracking disease progressions and discovering biomarkers. For instance, technological innovations rendered NGS feasible and affordable through higher levels of sequencing and declining costs. The use of NGS for drug discovery, clinical trials, and pharmacogenomics is being led by biopharmaceutical and biotech organizations. Public and private investments in genomics expenditure are also favorable towards a healthy market condition for the participants. The search for precision medicine globally continues to fuel growth demand for increasingly target-application and diversified NGS kits. With the transforming healthcare industry, NGS kits are finding broader use to provide personalized treatment.

KEY FINDINGS

• Market Size and Growth: The global next-generation sequencing (NGS) kits market is expected to grow to USD 6.2 billion in 2033, an increase from USD 2.5 billion in 2024 at a CAGR of 10.7%.
• Key Market Driver: According to estimates from the World Health Organization, approximately 1 in 10 people worldwide are impacted by a rare disease, many of which are genetically based, increasing demand for NGS kits.
• Major Market Restraint: Though advanced sequencing instruments can range in price from hundreds of thousands to more than a million dollars, many small laboratories lack this capability, limiting in-house NGS operations.
• Emerging Trends: There have been increased capabilities to optimize next-generation sequencing workflows to use artificial intelligence and machine learning algorithms. These methods increase the speed and accuracy of data analysis and increase the speed and efficiency of genomic interpretation and insights.
• Regional Leadership: In 2023, North America had 49.35% of the global NGS market share, demonstrating its dominance in kit consumption and related technologies/core infrastructure.
• Competitive Landscape: The top participants in the NGS kits market are Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, BGI, PerkinElmer, Agilent Technologies, QIAGEN, Macrogen, and Eurofins. These listed participants reflect the competitive landscape of the NGS kits market.
• Market Segmentation: The NGS kits market is segmented into consumables, platforms, and bioinformatics tools, where consumables are an essential piece of the overall sequencing workflow.
• Recent Development: In December 2023, Oxford Nanopore commercialized their TurBOT benchtop instrument, which allows for automated basecalling, data analysis, automated extraction, and library preparation of a number of samples within a single instrument.

COVID-19 IMPACT

COVID-19 Drove NGS Kit Demand, Fueling Significant Market Growth

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

 Particularly as researchers hurried to sequence the SARS-CoV-2 virus and learn its mutations, the COVID-19 epidemic greatly benefited the Next-Generation Sequencing (NGS) Kits Market and functioned as a catalyst for genomic research. The need for real-time surveillance increased worldwide demand for sequencing kits in clinical and research facilities. Governments and private companies sped market expansion by raising funding for NGS-based research and monitoring initiatives. Especially for tracking variations, the epidemic also pushed the integration of NGS into regular clinical diagnostics. Laboratories all around increased their genomic testing capacity to satisfy the never-before-seen demand. The pandemic therefore caused a sharp increase in NGS kit sales and usage. This phase built capacity and long-term awareness that will help the market even after the pandemic.

LATEST TRENDS

Single-cell Sequencing Drives NGS Kit Market Growth with Advanced Insights

 The quick development of single-cell sequencing techniques is among the most powerful trends in the NGS Kit Market. Especially in cancer and immunology, these technologies let individual cells be examined, therefore providing unmatched understanding of cell behavior and disease progression. Nonexpert labs are increasingly using user-friendly and automated single-cell sequencing tools. Furthermore, artificial intelligence and machine learning integration in data analysis of sequencing enhances diagnosis accuracy and interpretation. The usage of NGS in fast pathogen detection and surveillance—which gained momentum during COVID-19—is another growing trend. Also growing is the use of cloud-based platforms for data sharing and cooperation. Given its depth and accuracy, single-cell sequencing is set to revolutionize both research and medical fields among all trends.

•   
•   
  

  Request a Free sample to learn more about this report

    

NEXT-GENERATION SEQUENCING (NGS) KITS MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Blood Test, Saliva Test and Urine Test

• Blood Test: Because of their great applicability and somewhat invasive character, blood-based NGS assays are quite preferred. For liquid biopsies, these kits are often employed in oncology to allow the detection of circulating tumor DNA and track response to therapy. They are also used to find inherited genetic problems and prenatal testing. Blood tests are absolutely vital in individualized medicine as well as diagnosis because of the real-time insights they offer. Better sensitivity and specificity in more current kits are accelerating usage throughout medical contexts. Regular healthcare processes now include blood-based NGS kits more and more.

• Saliva Test: Because they are simple to use, noninvasive collection methods, and convenient, saliva-based NGS kits are increasingly popular. Consumer genetics businesses, including ancestry tracking and wellness-related genetic testing, make great use of these kits. Furthermore, useful in pharmacogenomic research, saliva samples allow tailored medication strategies based on genetic information. Advanced extraction methods have raised the DNA yield and quality from saliva, thereby improving test accuracy. Their simple collection method makes them perfect for senior and pediatric groups. Additionally, gaining use in epidemiological and lifestyle research are saliva-based kits. Additional fuel for expansion is the advent of direct-to-consumer genetic testing solutions.

• Urine Test: Mostly used for non-invasive monitoring and identification of genitourinary cancers, urine-based NGS systems are becoming a growing component of the market. These exams can assist in finding tumor DNA, tracking disease recurrence, and evaluating organ transplant rejection. Although not yet as prevalent as blood- or saliva-based testing, urine tests have particular benefits like painless sample collection and great patient adherence. Technological upgrades are improving the sensitivity and dependability of these sets for early detection. They are also under investigation for metabolomic and microbiome experiments. Longitudinal disease monitoring is becoming more and more reliant on urine samples by researchers. Demand for urine-based NGS kits is projected to increase dramatically as clinical validation expands.

By Application

Based on application, the global market can be categorized into Academic Research, Clinical Research and Hospitals and Clinics

• Academic Research: Academic studies employ NGS kits to facilitate transcriptomics, genomics, and epigenetics studies. Research institutes and universities make use of the kits for genome mapping, comparative genomics, and gene expression profiling. They work on pathways at the molecular level, evolutionary biology, and functional genetics. Grants from the government and non-government agencies enable NGS to be utilized intensively in research. Collaborative research projects involving universities and biotechnology companies are speeding up development. Additionally, in order to educate the future generation of researchers, experiential education in NGS is being integrated into school curricula. Academic researchers are increasingly attracted to cost-effective and multi-purpose kits. While research goals alter, academic institutions remain constant for the NGS kit market.

• Clinical Research: In medical research, the uses of NGS are important to establish disease pathophysiology, patient stratification, and therapeutic response. They are mainly used in research on neurological diseases, cancer treatments, and genetic orphan diseases. Pharmaceutical development requires high-fidelity data and regulatory acceptability by clinical-grade kits; biopharmaceutical firms apply these technologies to pharmacogenomic studies and biomarker validation. Increased demand for personalized therapies is driving next-gen sequencing demand for clinical trials. The market is being broadened by additional approvals of NGS-based companion diagnostics by regulatory agencies. Clinical research facilities partner with sequencing service providers for turnkey offerings. This segment is expected to grow along with targeted therapies and precision medicine.

• Hospitals and Clinics: Hospitals and clinics are increasingly employing NGS tools for real-time diagnostic purposes in oncology, infectious illness, and rare genetic illness areas. Personalized treatment choices based on genomic profiling are made possible by the inclusion of NGS into clinical processes. Especially revolutionary in oncology, NGS helps to find actionable mutations. Point-of-care NGS systems' development is opening up rapid diagnostics as a possibility in everyday as well as emergency care. Hospital laboratories are now able to perform in-house testing thanks to training programs and better sequencing infrastructure. Adoption is also aided by the growing coverage of NGS-based diagnostics' refund. In a number of disorders, clinical recommendations now favor NGS as a basis of care. Translating genomic knowledge into patient care depends on hospitals, a vital node.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Increasing Frequency of Genetic Diseases Drives Growth

Early and precise diagnosis is greatly desired in the increasing load of genetic disorders such as cystic fibrosis, Duchenne muscular dystrophy, and many inheritable cancers. NGS kits facilitate comprehensive analysis of gene alteration and copy number variation, thus facilitating decision-making in clinicians. These are most useful in neonatal and pediatric practice for congenital disease diagnosis. Early detection can profoundly enhance the success of treatment and reduce long-term health expenditure. Awareness among healthcare practitioners and patients of the advantage of genetic screening is propelling kit utilization. Charities and governments also support genetic disease identification. Due to their widespread application, existing diagnostics are highly dependent on NGS platforms.

Technical Developments in NGS Fuels Demand

Technological advances in sequencing have significantly lowered the cost and time of genomic discovery. Better throughput, accuracy, and usability for newer systems make them more affordable for the masses. For laboratory scientists, automation of library preparation and workflow streamlining are becoming ever more attainable. Integrate NGS platforms with cloud computing and AI-driven analytics, and data interpretation becomes more efficient, faster, and precise. Handheld sequencers are enabling new areas of NGS use to be introduced into point-of-care diagnosis and field diagnosis. Clinics and schools are employing such technology. Advances in the future will surely improve NGS device flexibility and scalability.

Restraining Factor

High Costs and Limitations Hinder NGS Market Growth Globally

Especially in the case of small and mid-sized labs, the prohibitively high initial cost of buying NGS equipment and reagents remains a significant barrier. The cost is further supplemented by infrastructure requirements, such as secure storage of data and bioinformatics capability. Handling high-complexity genomic information requires skilled people and, thus, increases operational costs. Scant expertise in new markets also restricts penetration. Lack of suitable insurance coverage and administrative reimbursement policies further limit adoption. World market expansion is dependent on overcoming the cost-specific challenges.

NGS Kit Market Growth Driven by Personalized Medicine and Partnerships

Opportunity

For Next-Generation Sequencing (NGS) Kits Market Growth, the change to tailored medicine presents great possibilities. In oncology, cardiology, and autoimmune illnesses, customized treatment plans based on genetic profiling are becoming increasingly popular. Pharmaceutical firms are more often utilizing NGS kits to create companion diagnostics and targeted medicines. Governments worldwide are starting genomics projects to advance precise health approaches.

Demand for sequencing kits is expected to increase as both doctors and patients see the advantages of personalized treatment. Collaborations between sequencing companies and healthcare professionals are enabling more general adoption. This pattern sets the NGS kits sector up for ongoing growth over the next few years.

Market Growth in NGS Faces Challenges in Data Management and Interpretation

Challenge

Users still find one of the main difficulties in managing the enormous amounts of NGS-generated data. Sophisticated bioinformatics tools and qualified experts are necessary for correct interpretation; however, these are not always readily available. Constant technical challenges involve data format standardization and cross-platform compatibility assurance.

Diagnostic mistakes and effects on patient results can come from data misinterpretation. Important difficulties in clinical and research environments also come from data security and privacy issues. Data use is complicated further by the demand for ethical standards and regulatory compliance. Maximizing NGS technology calls for solving these problems first.

•   
•   
  Request a Free sample to learn more about this report

    

NEXT-GENERATION SEQUENCING (NGS) KITS MARKET REGIONAL INSIGHTS

• North America

North America's Strong Ecosystem Drives Next-Gen Sequencing Market Growth

Early technological development and a highly developed research network allow North America to dominate the Next Generation Sequencing (NGS) Kit Market. Research universities, market participants, and high healthcare spending create demand for the growth of the market. Being a solid group of biotechnology companies and academia, the United States Next-Generation Sequencing (NGS) Kits market is the global leader. Through support of huge genomics projects and public health projects in organizations such as NIH, the government encourages large-scale adoption. Proper payment policies and regulatory approaches facilitate adoption within the clinical environment. Boston and California's entrepreneurial technology centers persistently set international standards. North America's early lead in genomics allows it to be one of the main contributors to the form of the market.

• Europe

Europe's Genomics Efforts Significantly Drive NGS Kit Market Growth

With its robust academic community, healthcare infrastructure, and regulatory backing, Europe is a major player in the worldwide Next-Generation Sequencing (NGS) Kits Market Share. Personalized medicine and genetic testing projects are receiving significant financial backing in countries including the UK, France, and Germany. Cross-border genetic research and data exchange have been made possible by EU-funded cooperative efforts. The area also stresses ethical standards and data privacy, which increase people's trust in genetic testing. Public health organizations are including NGS in population screening initiatives. European companies and research centers are creating affordable and effective sequencing options. Europe's comprehensive approach to genomics helps it to be a major force behind market expansion.

• Asia

Asia's NGS Kits Market Growth Driven by Innovation and Demand

Fueled by rising healthcare needs, quick urbanization, and technological advancement, Asia is becoming a powerhouse in the NGS kits market. Countries like China, Japan, South Korea, and India are putting funds into genomics infrastructure and public health genomics programs. Affordable NGS solutions from local manufacturers are making technology more widely available. Growing knowledge of genetic disorders and customized medicine is driving usage across healthcare systems. Cooperative research between universities and international companies is speeding up innovation. The great population of Asia offers a sizable repository for data generation and genetic studies. The increasing capacity of the area makes it set to lead in genomics in the years to come.

KEY INDUSTRY PLAYERS

Strategic Innovations and Partnerships Drive NGS Kits Market Growth Globally

By concentrating on constant innovation, strategic partnerships, and worldwide growth, important market players are transforming the next-generation sequencing (NGS) kits market. Firms such as Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and BGI are leading this change. To introduce high-throughput, cost-effective, user-friendly kits, these players invest significantly in research and development. Strategic acquisitions and joint ventures enable them to expand their product line and enter new markets. Their efforts in providing training and support help improve end-user confidence and efficiency. Partnerships with clinical laboratories and universities are accelerating the acceptance of NGS kits. These businesses are not only growing geographically but also diversifying over uses, including oncology, infectious diseases, and rare disorder diagnostics. Their initiatives are vital in helping next-generation sequencing become more mainstream and influential throughout research and healthcare fields.

List Of Top Next-Generation Sequencing (Ngs) Kits Companies

• Swift Biosciences (U.S.)
• Menarini Silicon Biosystems (ITALY)
• BGI (CHINA)
• Ampliqon A/S (DENMARK)
• QIAGEN (NETHERLANDS)

KEY INDUSTRY DEVELOPMENTS

March 2021: Illumina introduced in March 2021 a next-generation sequencing kit designed for quick detection and identification of infectious disease pathogens, including SARS-CoV-2. This unique kit lets one concurrently sequence several pathogens in a single test, therefore increasing diagnostic accuracy and speed. It helps to shorten laboratory turnaround time by including cloud-based analysis systems and automated workflows. Enhancement of surveillance and outbreak monitoring capabilities helps the kit to support public health initiatives. It also broadens NGS's use past conventional genetic testing to manage infectious diseases. Illumina gained a sizable market share by meeting a crucial need during the COVID-19 epidemic. This invention shows the company's dedication to fitting NGS tools to actual medical problems.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.